CY2411B1 - Compositions. - Google Patents

Compositions.

Info

Publication number
CY2411B1
CY2411B1 CY0000022A CY0000022A CY2411B1 CY 2411 B1 CY2411 B1 CY 2411B1 CY 0000022 A CY0000022 A CY 0000022A CY 0000022 A CY0000022 A CY 0000022A CY 2411 B1 CY2411 B1 CY 2411B1
Authority
CY
Cyprus
Prior art keywords
compositions
Prior art date
Application number
CY0000022A
Other languages
English (en)
Inventor
Isabelle Thielemans
Isabelle Richard
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of CY2411B1 publication Critical patent/CY2411B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CY0000022A 1993-05-25 2000-06-06 Compositions. CY2411B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions

Publications (1)

Publication Number Publication Date
CY2411B1 true CY2411B1 (en) 2004-11-12

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0000022A CY2411B1 (en) 1993-05-25 2000-06-06 Compositions.

Country Status (38)

Country Link
US (1) US5741806A (xx)
EP (1) EP0700290B1 (xx)
JP (1) JP2965703B2 (xx)
KR (1) KR100297212B1 (xx)
CN (1) CN1106194C (xx)
AP (1) AP544A (xx)
AT (1) ATE183643T1 (xx)
AU (1) AU680918B2 (xx)
BE (1) BE1007158A3 (xx)
BR (1) BR1100046A (xx)
CA (1) CA2162919C (xx)
CO (1) CO4230094A1 (xx)
CY (1) CY2411B1 (xx)
CZ (1) CZ291041B6 (xx)
DE (1) DE69420266T2 (xx)
DK (1) DK0700290T3 (xx)
EC (1) ECSP941088A (xx)
ES (1) ES2136198T3 (xx)
FR (1) FR2705569B1 (xx)
GB (2) GB9310756D0 (xx)
GR (1) GR3031669T3 (xx)
HR (2) HRP940315B1 (xx)
HU (1) HU227121B1 (xx)
IE (1) IE80632B1 (xx)
IL (1) IL109749A (xx)
IS (1) IS1868B (xx)
IT (1) IT1272990B (xx)
MY (1) MY111445A (xx)
NO (1) NO306448B1 (xx)
NZ (1) NZ267415A (xx)
PE (1) PE13395A1 (xx)
PL (1) PL175578B1 (xx)
RU (1) RU2132684C1 (xx)
SA (1) SA94150003B1 (xx)
SG (1) SG48119A1 (xx)
SI (1) SI0700290T1 (xx)
WO (1) WO1994027599A1 (xx)
ZA (1) ZA943593B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003522103A (ja) * 1998-06-15 2003-07-22 セプラコア インコーポレーテッド 無呼吸、過食症およびその他の障害を治療するための光学的に純粋な(−)−ノルシスアプリドの使用
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
EP1089733B1 (en) 1998-06-15 2005-03-23 Sepracor Inc. Use of optically pure (+)-norcisapride for treating irritable bowel syndrome
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
AU7931301A (en) * 2000-08-04 2002-02-18 Dmi Biosciences Inc Method of using diketopiperazines and composition containing them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) * 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
NO306448B1 (no) 1999-11-08
FR2705569B1 (fr) 1995-11-10
PL311721A1 (en) 1996-03-04
PL175578B1 (pl) 1999-01-29
DE69420266D1 (de) 1999-09-30
HRP940315A2 (en) 1996-08-31
NO954783L (no) 1995-11-24
IL109749A0 (en) 1994-08-26
AU680918B2 (en) 1997-08-14
FR2705569A1 (fr) 1994-12-02
DK0700290T3 (da) 2000-03-13
ITRM940322A1 (it) 1995-11-24
CA2162919C (en) 1999-07-20
GB2279008B (en) 1997-06-18
JPH08510457A (ja) 1996-11-05
NO954783D0 (no) 1995-11-24
IL109749A (en) 1999-03-12
EP0700290B1 (en) 1999-08-25
KR100297212B1 (ko) 2001-10-24
ATE183643T1 (de) 1999-09-15
MY111445A (en) 2000-05-31
CZ308595A3 (en) 1996-06-12
IT1272990B (it) 1997-07-01
SI0700290T1 (en) 1999-12-31
AP9400643A0 (en) 1994-07-31
HRP970315A2 (en) 1999-04-30
HRP940315B1 (en) 2000-12-31
ZA943593B (en) 1995-02-13
EP0700290A1 (en) 1996-03-13
BE1007158A3 (fr) 1995-04-11
AP544A (en) 1996-10-11
IE80632B1 (en) 1998-10-21
GB2279008A (en) 1994-12-21
JP2965703B2 (ja) 1999-10-18
BR1100046A (pt) 1999-11-23
HUT74867A (en) 1997-02-28
ITRM940322A0 (it) 1994-05-24
SG48119A1 (en) 1998-04-17
GR3031669T3 (en) 2000-02-29
CN1124454A (zh) 1996-06-12
NZ267415A (en) 1997-10-24
DE69420266T2 (de) 1999-12-09
ES2136198T3 (es) 1999-11-16
US5741806A (en) 1998-04-21
HU9503375D0 (en) 1996-01-29
GB9409835D0 (en) 1994-07-06
CN1106194C (zh) 2003-04-23
CO4230094A1 (es) 1995-10-19
PE13395A1 (es) 1995-05-25
CZ291041B6 (cs) 2002-12-11
IS4168A (is) 1994-11-26
RU2132684C1 (ru) 1999-07-10
AU6970994A (en) 1994-12-20
WO1994027599A1 (en) 1994-12-08
HU227121B1 (en) 2010-07-28
CA2162919A1 (en) 1994-12-08
IE940420A1 (en) 1994-11-30
SA94150003B1 (ar) 2005-04-11
IS1868B (is) 2003-05-02
GB9310756D0 (en) 1993-07-14
ECSP941088A (es) 1994-11-16

Similar Documents

Publication Publication Date Title
EP0621279A3 (en) Siloxy-aluminoxane compositions.
ZA939656B (en) Microvicidal compositions.
EP0598412A3 (de) Hautschutzmittel zum Schutz der menschlichen Haut.
EP0634459A3 (de) Formulierungen.
PL315128A1 (en) Anti-pollutant compositions
IL110665A0 (en) Erection-inducing compositions
EP0655440A3 (de) Indol derivate.
EP0626135A3 (de) Fungizide Wirkstoffkombinationen.
EP0620222A3 (en) Tetrahydro-beta-carbolines.
EP0641704A3 (en) One wheel sled.
EP0671929A4 (en) COMPOSITIONS.
EP0620270A3 (en) Detergent compositions.
GB9318641D0 (en) Compositions
ZA946728B (en) Tocopherois.
EP0620223A3 (en) Tetrahydropyridoindole.
GB9323313D0 (en) Clenasing compositions
EP0664115A3 (en) Shampoo composition.
PH30815A (en) Composition.
GB9404236D0 (en) Cable-making compositions
EP0629346A3 (en) Pesticide mixtures.
EP0651043A3 (en) Fat composition.
EP0656409A3 (en) Coating compositions.
EP0641829A3 (en) Curable compositions.
EP0609763A3 (en) Ph-glasselectrode.
CY2411B1 (en) Compositions.